The Centre for Bioengineering and Biotechnology is a catalyst for advancing bioengineering and biotechnology research and innovation through industry collaborations and partnerships.
More than 150 faculty members, from every faculty on campus, are actively engaged with the centre, working in collaboration to provide a resource of varying expertise.
Our mandate is to build healthy, active partnerships between centre researchers and corporate members through collaborative projects, mutual interest building, and networking events.
To learn more about partnerships, please email us.
Vision:
The Centre for Bioengineering & Biotechnology (CBB) enables interdisciplinary research across the university to address global challenges in human health and help translate those research results rapidly into practice, policy and impactful health outcomes. Achieving this vision will help the University of Waterloo to cement an international reputation at the interface of technology and human health.
Mission:
To achieve this vision, CBB's mission is to:
- Enable knowledge translation and support of the interdisciplinary research community through seminars, networking opportunities, and support of student groups
- Be a conduit to Waterloo's ecosystem of unique health related R&D and clinical resources
- Cultivate relationships with key stakeholders in technology, human, animal and environmental health and practice including industry, hospitals, community, and international bodies
- Provide Project Coordination/Management for large/inter-institutional projects
Join us:
To become a member of CBB, you can start by filling out a quick survey. We will then be in touch to discuss further.
News
Celebrating innovation at the University of Waterloo
University of Waterloo hosts its first Biomedical Engineering and Technology Research Day.
Connecting innovators: The launch of Clinical Council
The article discusses the launch of the Clinical Council by the Centre for Bioengineering and Biotechnology (CBB), aimed at fostering collaboration between researchers and clinicians to address healthcare challenges. The council, consisting of six clinicians with diverse expertise, seeks to connect with health technology innovators and facilitate broader connections within the healthcare community. The article highlights the council's goals, upcoming events, and opportunities for engagement, emphasizing its role in bridging the gap between research and healthcare innovations.
Congratulations to Arya Amiri as he joins the Vanier scholars
Arya Amiri, a PhD student at the University of Waterloo's department of Systems Design Engineering, and a trainee in the Centre for Bioengineering and Biotechnology's Training in Global Biomedical Technology Research and Innovation program, has been awarded a prestigious Vanier Canada Graduate Scholarship for 2023.
Events
Interventional Psychiatry & Digital Interventions: Clinical & Emerging Research Perspectives
The Interventional Neuropsychiatry Program at the University of Toronto has three pillars with a focus on novel and emerging treatments in the realms of: A) Pharmacology (e.g., IV ketamine, nitrous oxide, psychedelics); B) Brain stimulation (e.g., rTMS, TI, FES); C) Digital Interventions/Therapeutics. The research program aims to understand mechanisms behind treatment response with an emphasis on digital data capture accompanied by application of AI/analytics. This talk will provide an overview of research paradigms in this emerging domain with a particular emphasis on activities within the Digital Pillar which houses the Digital Interventions & Intelligence Group (DiiG)
Clinical Council Engagement Session
The second opportunity for Engagement Sessions will occur in November 2024. Sessions are intended to provide face-to-face interactions with relevant Clinical Council members to discuss current or future project ideas, and develop potential partnerships, collaborations, and receive expert clinical perspectives and feedback. Priority for this round of talks will be given to research applicants whose research areas align with the Clinical Problem Space Talks.